Tabor Asset Management LP bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 168,400 shares of the pharmacy operator's stock, valued at approximately $1,881,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Curat Global LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $27,000. Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at $27,000. Colonial Trust Co SC boosted its stake in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,297 shares in the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock valued at $50,000 after purchasing an additional 1,000 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 83.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 5,312 shares of the pharmacy operator's stock valued at $50,000 after purchasing an additional 2,422 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on WBA shares. Wall Street Zen started coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, May 21st. They issued a "hold" rating for the company. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Morgan Stanley reissued an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $10.59.
Get Our Latest Stock Report on Walgreens Boots Alliance
Walgreens Boots Alliance Trading Down 0.0%
NASDAQ WBA traded down $0.01 during trading on Friday, hitting $11.51. The company had a trading volume of 834,798 shares, compared to its average volume of 19,058,346. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $13.25. The company has a market cap of $9.96 billion, a price-to-earnings ratio of -1.58, a price-to-earnings-growth ratio of 1.35 and a beta of 0.78. The company's fifty day moving average is $11.35 and its 200-day moving average is $11.01.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. Walgreens Boots Alliance's quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $0.63 EPS. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Insider Activity
In other news, Chairman Stefano Pessina acquired 832,258 shares of Walgreens Boots Alliance stock in a transaction on Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman owned 145,621,079 shares in the company, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 17.50% of the stock is currently owned by insiders.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.